OGN News and Press, Organon & Co. From 11/10/25

2025-11-10 08:12:19 ET Seeking Alpha (Seeking Alpha) More on Organon Organon: Critical Assessment Of The Audit Committee Investigation Results The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products Organon: Muted H2 2025 Ahead...

2025-11-10 07:44:05 ET More on Organon Organon: Critical Assessment Of The Audit Committee Investigation Results The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products Organon: Muted H2 2025 Ahead, But Distressed Valuation And Manageable Debt Makes I...

2025-11-10 07:32:07 ET More on Organon Read the full article on Seeking Alpha For further details see: Organon Non-GAAP EPS of $1.01 beats by $0.08, revenue of $1.6B beats by $20M

Third quarter 2025 revenue of $1.602 billion, up 1% as-reported and down 1% excluding the impact of foreign currency Third quarter 2025 diluted earnings per share of $0.61 and non-GAAP Adjusted diluted earnings per share of $1.01 Third quarter 2025 net income of $160 million and Adjusted ...

VEON Ltd. (VEON) is expected to report $1.21 for Q3 2025 eToro Group Ltd. (ETOR) is expected to report $0.52 for Q3 2025 KE Holdings Inc American Depositary Shares (each representing three Class A) (BEKE) is expected to report $0.09 for Q3 2025 CoreWeave Inc. (CRWV) is expected to rep...

2025-11-09 18:00:29 ET Major earnings expected before the bell on Monday include: Organon & Co. ( OGN ) Starwood Property Trust ( STWD ) Tyson Foods ( TSN ) Global Ship Lease ( GSL ) EVgo ( EVGO ) Read the full article on Seeking Alpha ...

2025-11-09 08:16:01 ET Earnings in the upcoming week will spotlight a diverse lineup across media, technology, energy, aerospace, and consumer sectors.... Read the full article on Seeking Alpha For further details see: Earnings week ahead: DIS, CSCO, OXY, PLUG, B, AMAT, JD, ...

Sub-analysis of children with atopic dermatitis aged 2-17 in pivotal Phase 3 trials revealed early and clinically meaningful improvements in vIGA-AD ™ and EASI-75 (skin clearance and severity), POEM (patient-reported outcomes) and PP-NRS (itch), regardless of comorbidity status, at wee...

2025-11-07 09:38:24 ET More on Organon Organon: Critical Assessment Of The Audit Committee Investigation Results The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products Organon: Muted H2 2025 Ahead, But Distressed Valuation And Manageable Debt Makes I...

2025-11-07 07:35:19 ET More on Organon Organon: Critical Assessment Of The Audit Committee Investigation Results The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products Organon slides to record low after leadership shakeup linked to wholesaler sales p...